US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist
  • 3.270
  • +0.130+4.14%
Close Feb 14 16:00 ET
  • 3.300
  • +0.030+0.91%
Post 20:01 ET
965.85MMarket Cap-5.36P/E (TTM)

About AbCellera Biologics Company

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Company Profile

SymbolABCL
Company NameAbCellera Biologics
Listing DateDec 11, 2020
Issue Price20.00
Founded2012
CEODr. Carl L.G. Hansen, PhD
MarketNASDAQ
Employees586
Fiscal Year Ends12-31
Address2215 Yukon Street
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Y 0A1
Phone1-604-559-9005
Websitehttp://www.abcellera.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carl L.G. Hansen, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 714.94K
  • Tryn Stimart
  • Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
  • 667.69K
  • Andrew Booth
  • Chief Financial Officer and Principal Accounting Officer
  • 674.56K
  • Dr. Veronique Lecault, PhD
  • Director and Chief Operating Officer
  • 650.59K
  • John S. Montalbano, C.F.A.
  • Independent Director
  • 77.50K
  • Dr. Michael Hayden
  • Lead Independent Director
  • 105.00K
  • Dr. Andrew W. Lo
  • Independent Director
  • 55.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
HNAC Technology
300490
+19.95%
5
Cubic Digital Technology
300344
+19.64%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.